HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation of a modified commercial assay for the detection of rubella-specific IgG in oral fluid for use in population studies.

Abstract
Matching serum and oral fluid (saliva) samples were collected from 369 subjects in Tunisia in 2002, from a city in the north and a rural district in the south. Rubella-specific IgG was detected in sera by commercial ELISA (Dade Behring) and in matching oral fluids by two methods, a previously described IgG-capture ELISA (GACELISA) [J. Clin. Microbiol. 37 (1999) 391] and the Dade Behring ELISA with the assay protocol modified for use with oral fluids. Total IgG concentration of oral fluids was also measured. Rubella-specific IgG was detected in 289 (78.3%) sera overall. Differences in the age distribution of the study population in the north and south led to a higher prevalence being found in the north (86.2%) than in the south (71.8%). This difference was reflected in the oral fluid rubella-specific IgG results. With GACELISA, rubella-specific IgG was detected in 79.4% of oral fluids from the north and 69.7% from the south and with the modified Dade Behring assay, in 81.4% of oral fluids from the north and in 64.9% from the south. The sensitivity and specificity of GACELISA in comparison to results from the matching sera were 92.4 and 93.2%, respectively. The sensitivity and specificity of the modified Dade Behring ELISA were 89.8 and 92.0%, respectively. Total IgG concentration in oral fluid showed a weak correlation (r=0.19) with the modified Dade Behring results and with samples where total IgG was >7.5 mg/l, the sensitivity and specificity were 94.4 and 90.0%, respectively. Twenty-nine oral fluids, which gave false negative rubella-specific IgG results with the modified Dade Behring ELISA, had a lower mean total IgG concentration than 256 oral fluids which gave concordant positive results (7.0mg/l versus 15.8 mg/l, P<0.001). The study validated the modified Dade Behring ELISA, providing an alternative to the GACELISA for assessing levels of rubella immunity for population studies using oral fluid samples.
AuthorsA Ben Salah, A Zaâtour, L Pomery, B J Cohen, D W G Brown, N Andrews
JournalJournal of virological methods (J Virol Methods) Vol. 114 Issue 2 Pg. 151-8 (Dec 2003) ISSN: 0166-0934 [Print] Netherlands
PMID14625050 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Reagent Kits, Diagnostic
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Antibodies, Viral (analysis, blood)
  • Antibody Specificity
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunoglobulin G (analysis, blood)
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Reagent Kits, Diagnostic
  • Rubella (epidemiology)
  • Rubella virus (immunology)
  • Saliva (immunology)
  • Sensitivity and Specificity
  • Seroepidemiologic Studies
  • Tunisia (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: